Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00191997
Status:
COMPLETED
Last Update Posted:
2006-07-25
First Post:
2005-09-12
Brief Title:
Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Bipolar Disorder |
Keywords: